Fresenius Medical Care (FMS) reported Q1 earnings Tuesday of 0.43 euro ($0.50) per basic share, down from 0.52 euro a year earlier.

Analysts polled by FactSet expected 0.52 euros.

Revenue for the quarter ended March 31 was 4.61 billion euros, compared with 4.88 billion euros a year earlier.

Analysts surveyed by FactSet expected 4.62 billion euros.

For 2026, the company continues to expect "broadly flat" revenue growth compared with a year earlier. Analysts polled by FactSet expect 19.35 billion euros.